Bessemer Group Inc. Purchases 66,908 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Bessemer Group Inc. increased its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 22.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 361,958 shares of the company's stock after acquiring an additional 66,908 shares during the quarter. Bessemer Group Inc. owned 0.73% of Prestige Consumer Healthcare worth $31,118,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Opal Wealth Advisors LLC acquired a new stake in shares of Prestige Consumer Healthcare during the first quarter valued at approximately $38,000. CIBC Private Wealth Group LLC raised its holdings in shares of Prestige Consumer Healthcare by 48.9% during the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after acquiring an additional 152 shares during the period. Headlands Technologies LLC acquired a new stake in shares of Prestige Consumer Healthcare during the fourth quarter valued at approximately $40,000. McIlrath & Eck LLC raised its holdings in shares of Prestige Consumer Healthcare by 19.1% during the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after acquiring an additional 154 shares during the period. Finally, Johnson Financial Group Inc. acquired a new stake in shares of Prestige Consumer Healthcare during the fourth quarter valued at approximately $93,000. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Stock Down 0.2%

PBH traded down $0.15 on Friday, reaching $81.00. 855,797 shares of the company traded hands, compared to its average volume of 302,619. The stock's 50 day moving average price is $84.14 and its 200-day moving average price is $82.44. Prestige Consumer Healthcare Inc. has a 52-week low of $64.94 and a 52-week high of $90.04. The company has a market cap of $4.00 billion, a price-to-earnings ratio of 18.88, a PEG ratio of 2.43 and a beta of 0.45. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.20 and a quick ratio of 2.82.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $1.32 EPS for the quarter, beating analysts' consensus estimates of $1.30 by $0.02. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The firm had revenue of $296.52 million for the quarter, compared to the consensus estimate of $289.36 million. During the same period in the previous year, the firm posted $1.02 earnings per share. The firm's revenue was up 7.0% on a year-over-year basis. On average, sell-side analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, May 17th. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.